Research Article

Perbedaan kadar protein C, protein S, dan antitrombin III pada pasien dengan Sindrom Koroner Akut (SKA) di RSUP H. Adam Malik, Medan, Indonesia

Maisyaroh Tiurma Anggraini Saragih , Adi Koesoema Aman, Nizam Akbar

Maisyaroh Tiurma Anggraini Saragih
Departemen Patologi Klinik, Fakultas Kedokteran Universitas Sumatera Utara, RSUP H. Adam Malik, Medan, Indonesia. Email: mtasaragih@gmail.com

Adi Koesoema Aman
Departemen Patologi Klinik, Fakultas Kedokteran Universitas Sumatera Utara, RSUP H. Adam Malik, Medan, Indonesia

Nizam Akbar
Departemen Kardiologi dan Kedokteran Vaskular, Fakultas Kedokteran Universitas Sumatera Utara, RSUP H. Adam Malik, Medan, Indonesia
Online First: December 01, 2019 | Cite this Article
Saragih, M., Aman, A., Akbar, N. 2019. Perbedaan kadar protein C, protein S, dan antitrombin III pada pasien dengan Sindrom Koroner Akut (SKA) di RSUP H. Adam Malik, Medan, Indonesia. Intisari Sains Medis 10(3). DOI:10.15562/ism.v10i3.500


Background: Acute coronary syndrome (ACS) is a life-threatening condition where coronary artery blockage results from thrombosis and leads to ischemia. Individuals with partial deficiency of protein C, protein S or antithrombin III have been found to play a role in increasing the risk of thrombosis. This study aims to determine differences in levels of protein C, protein S and antithrombin III in patients with ACS.

Methods: A cross-sectional study was carried out among 60 patients who were treated at H. Adam Malik General Hospital Medan and had fulfilled the inclusion and exclusion criteria through consecutive sampling techniques. Protein C, protein S and antithrombin III were examined with Coatron A4. Bivariate analysis was used to determine differences in the mean levels of protein C, protein S, and antithrombin III in ACS compared with healthy controls. Data were analyzed using SPSS version 17 for Windows.

Results: There were a significant difference in S protein levels between the STEMI, NSTEMI, and control groups (P <0.05). S protein levels in the STEMI group were significantly lower compared to NSTEMI and control (P <0.05). However, there were no significant differences in levels of protein C and AT-III between the STEMI, NSTEMI and control groups (P> 0.05).

Conclusion: There were no significant differences in ATIII and protein C levels between the STEMI, NSTEMI, and ATIII groups. However, in the S protein parameter, the S protein level was significantly different between STEMI, NSTEMI and the control group.

References

Overbaugh KJ. Acute Coronary Syndrome. Am J Nurs. 2009;109(5):42–52

Rhee JW, Sabatine MS, Lilly LS. Acute Coronary Syndromes. In Lilly LS: Pathophysiology of Heart Disease: Acollaborative Project of Medical Students and Faculty. 5th ed. Baltimore: LW&W. 2011:161-165

PERKI. Pedoman Tatalaksana Hipertensi pada Penyakit Kardiovaskular. Edisi ke-3. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia, Jakarta. 2015

Ismail D, Harun S, Alwi I, Tambunan KL, Effendy S. Anti-thrombin III, Protein C and Protein S Deficiency in acute coronary syndrome. Medical Journal of Indonesia. 2002;11(2):87-92.

Artha IMJ, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag. 2019; 15: 149–157

Pertiwi GAR, Aryawangsa AAN, Prabawa IPY, Manuaba IBAP, Bhargah A, Ratni NWS, Budiana IPG. Factors associated with visit-to-visit variability of blood pressure in hypertensive patients at a Primary Health Care Service, Tabanan, Bali, Indonesia. Family Medicine and Community Health. 2018;6(1):191-199

Bhargah A, Muliarta M, Prabawa IPY, Manuaba IBAP, Bhargah V. Post-Exercise Hypotension Phenomenon in Elderly after Aerobic Exercise. Journal of Global Pharma Technology. 2018; 10(6):323-327

Derhaschnig U, Laggner A, Roogla M, Kapiotis S, Marsik C, et al. Evaluation of Coagulation Markers for early Diagnosis of Acute Coronary Syndromes in the Emergency Room. Clin Chem. 2002;48(11):1924-30.

McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owen CG, et al. 2008. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J. 2008;29(23):2843-50.

Tumade B, Jim EL, Joseph VFF. Prevalensi Sindrom Koroner Akut di RSUP Prof. Dr. R. D. Kandou Manado periode 1 Januari 2014 – 31 Desember 2014. Journal e-Clinic. 2016;4(1):223-230

Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: Process, Indicators, Risk Factors and New Hopes. Int J Prev Med. 2014;5(8):927–946

Sumartono W, Sirait AM, Holy M, Thabrany H. Smoking and Socio-Demographic Determinant of Cardiovascular Diseases among Males 45+ Years in Indonesia. Int J Environ Res Public Health. 2011;8(2):528–539.

Ting P, Chua TS, Wong A, Sim LL, Tan VW, Koh TH. Trend in mortality from acute myocardial infarction in coronary care unit. Ann Acad Med Singapore. 2007;36(12):974-9.

Nababan D. 2008. Hubungan Faktor Risiko dan Karakteristik Penderita dengan Kejadian Penyakit Jantung Koroner di RSU Dr. Pirngadi Medan Tahun 2008. [Tesis] Medan, Universitas Sumatera Utara. 2008

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137(12):e67-e492.

Vaziri ND, Kennedy SC, Kennedy D. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarcion and angina pectoris. Am J Med. 1994;96(6):571.

Callas PW, Tracy RP, Bovill EG, Cannon C, Thompson B, Mann KG.. The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Trial. J Thromb Thrombolysis. 1998;5(1):53-60.

Akruyek O, Akbal E, Gunes F. Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level. Arch Med Res. 2014;45(6):501-6.


No Supplementary Material available for this article.
Article Views      : 84
PDF Downloads : 42